Interleukin-7-based melanoma vaccine: Began a Phase I trial in nine patients that will use radiation to stop growth of the cell mixture, which then is injected

Targeted Genetics Corp. (TGEN), Seattle Product: Interleukin-7-based melanoma vaccine, in which patients' melanoma cells are mixed with a melanoma cell line engineered with IL-7/HyTK retroviral vector...